Day 2 – Thursday 12th SeptemberThursday, 12 September 2024 - EST/EDT (Eastern Daylight, GMT-4)

Following an industry rebound in 2023, the sector anticipates sustained positive momentum through 2025. A panel of senior executives from Tier 1 medtech examine current acquisition trends in 2024, offering insights and guidance on effective approaches for potential buyouts in Q4 and into 2025.

• Factors that strategics prioritize in their acquisition targets
• Areas where Tier 1 companies are making acquisitions
• Characteristics of a successful approach to acquisitions

Numerous medtech start-ups face failure due to a lack of alignment with market access principles and insufficient understanding of technology value drivers and future pricing strategies. To address this, a panel of medtech executives will discuss creating value and market adoption tactics for pioneering products, emphasizing direct demonstration of value to payers and providers.

• What does successful implementation truly look like
• Listening to the voice of the customer, finding product-market fit.
• How hospitals are adapting to digital innovations

Growing sustainability requirements have created industry-wide and system-level changes in the way the MedTech industry operates. Manufacturers are being held more accountable due to the emerging global legislation and a renewed global focus on adopting climate-neutral operations. Companies and investors need to adapt this sustainability mindset and implement tactical changes to compete and remain relevant, but no one organization can do it alone.

• The most pressing sustainability issues in the medtech industry
• Upholding sustainability principles to make your medtech innovation competitive and more attractive for funding and implementation
• Business strategies and approaches to meet sustainability goals
• The benefits of collaboration and partnerships (investors & strategics)
• Impending legislation changes and their threat to impact on company growth goals.

Entrepreneurs, investors, and industry partners will share insights on how startups can go beyond technology, emphasizing the importance of capital, people, and strategic partnerships in achieving significant milestones. The panel aims to guide companies in effectively identifying and leveraging these fundamentals for successful development.

• A-Z of fundraising
• Building your team
• Going through the stages of commercialisation
• Finding partners for scale

Navigating the unpredictable landscape of medtech doesn't guarantee success, but proactive and strategic steps can enhance your position for potential opportunities. Celebrating a successful exit in the competitive and ever evolving medtech space is undoubtedly rewarding, but achieving it is a challenging journey, given the need to stand out and position for success amidst intense competition. A panel of medtech leaders discuss what it really took to exit.

• Defining your endpoints
• Selecting your team and partners
• Strategic fundraising approaches
• Navigating common pitfalls for successful exits

The outcome of the 2024 Presidential Election in the United States has the potential to significantly impact the healthcare and life sciences sector, shaping policies, regulations, and funding priorities for years to come. With broader issues such as healthcare accessibility, affordability, and innovation, the decisions made by the incoming administration will have far-reaching consequences for stakeholders across the industry. This panel discussion seeks to explore the potential implications of the election outcome on the healthcare and life sciences sector, examining key areas of impact and identifying strategies for navigating the evolving landscape.

• Potential impact on drug pricing, approval and insurance
• For medical devices, will stricter regulations create a fallout akin to the MDR in Europe?
• Impact of cyber-security and AI legislation on digital health innovation and implementation

The healthcare industry continues to be a hotbed of innovation and investment, with a diverse range of players in the arena. What future trends are on the horizon and how can the industry continue to move forward as a cohesive sector, play to each others strengths, and ensure we move into 2025 informed and continue to bring proactive and preventative treatments to patients.

• Understanding the evolution of the patient journey
• Has AI actually delivered for healthcare in 2024?
• How will successful partnerships truly affect the industry – how will patients benefit?
• What future trends can we expect to see and what are the trends we can expect to forget?